Spotlight on in vitro quantitative assessment of skin sensitizing potency.
Join our upcoming webinar to explore the recent advancement in GARD® for quantitative assessment of skin sensitizing potency.
This session will present a meta-analysis of GARD® data covering over 200 chemicals, including three blinded datasets generated in collaboration with industry partners.
These data will demonstrate how GARD® can estimate a Point of Departure (PoD) and be incorporated into downstream strategies for Quantitative Risk Assessment (QRA), contributing to the assessment of safe use levels of chemicals.
You will learn how the assay can be used to predict LLNA EC3 values, Human NOELs, and GHS/CLP classifications (1A or 1B).
The webinar will last around 30 minutes, followed by a live Q&A. If you cannot attend the live event, make sure to register to get access to the recording.
Key topics
- An introduction to the prediction model, genomics, and machine learning technology.
- The GARD® assay’s performance in predicting PoD for QRA.
- How the GARD® assay ensures the safe use of ingredients in consumer products.
Speakers
